INOVIO PHARMACEUTICALS, INC.

AENEOS THERAPEUTICS

THERAPEUTICS;Research and development in the fields of pharmaceuticals, biopharmaceuticals and therapeutics; research and development in the field of personalized medicine and its delivery to patients; research and development in the field of oncology; research and development of personalized cancer treatments;

ASPIRE

Nucleic acid sequences and chemical reagents for medical and veterinary purposes;medical apparatus for delivering nucleic acid molecules, chemical reagents, plasmids, or vaccines via electroporation;

CELLECTRA

Medical apparatus for delivering nucleic acid molecules, for example plasmids, or vaccines to mammals or cells via electroporation;

CLOUDIMMUNITY

Vaccine preparations; Vaccines;CLOUD IMMUNITY;Research and development of vaccines and medicines;

CLOUDIMMUNITY

Vaccine preparations; Vaccines;Research and development of vaccines and medicines;

CLOUDIMMUNITY

Vaccine preparations; Vaccines;CLOUD IMMUNITY;Research and development of vaccines and medicines;

CLOUDVAX

Vaccine preparations; Vaccines;CLOUDVAX; CLOUD VACCINE;Research and development of vaccines and medicines;

CLOUDVAX

Vaccine preparations; Vaccines;Research and development of vaccines and medicines;

CLOUDVAX

Vaccine preparations; Vaccines;CLOUD VAX;Research and development of vaccines and medicines;

DBITE

Pharmaceutical compositions; Nucleic acid sequences for medical purposes; Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies or fragments thereof for immunotherapies for cancer;

DMAB

Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer and infectious diseases;

DMAB

Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer and infectious diseases;

DMAB

Pharmaceutical preparations containing nucleic acid sequences that encode monoclonal antibodies for the treatment of cancer and infectious diseases; pharmaceutical preparations, and agents; vaccines;

GENESWITCH

pharmaceutical preparations of modified steroid hormone receptors for medical use in gene therapy and clinical medical laboratory use;GENE SWITCH;

IMMUNO-INGENUITY

Pharmaceutical preparations for human use for the treatment and prevention of cancer and infectious diseases; pharmaceutical preparations for human use, namely, antibiotics, antifungals and anti-virals;Printed matter, namely, booklets, brochures, pamphlets and newsletters on the subject of pharmaceuticals and healthcare;Providing health information to health care professionals and patients on the topic of health issues and awareness;

IMMUNO-INGENUITY

Pharmaceutical preparations for human use for the treatment and prevention of cancer and infectious diseases; pharmaceutical preparations for human use, namely, antibiotics, antifungals and anti-virals;Providing health information to health care professionals and patients;

INOVIO

Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines;

INOVIO

Vaccine preparations; Vaccines; Pharmaceuticals, namely, pharmaceutical products, preparations and substances for the prevention and treatment of cancer and infectious diseases;

INOVIO

Vaccine preparations; Vaccines; Pharmaceuticals, namely, pharmaceutical products, preparations and substances for the prevention and treatment of cancer and infectious diseases;

OMNIVAX

Research and development of vaccines and medicines;

PENNVAX

Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention or treatment of acquired immunodeficiency syndrome (AIDS);

PENNVAX

Pharmaceutical compositions for the prevention and treatment of acquired immunodeficiency syndrome, cancer and infectious diseases; Nucleic acid sequences for medical purposes; Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention and treatment of acquired immunodeficiency syndrome (AIDS);

SYNCON

Nucleic acid sequences and chemical reagents for medical and veterinary purposes, specifically excluding chemical reagents for clinical diagnostic medical purposes;

VGX

scientific testing and analysis of cGMP (current good manufacturing practice) processes in the field of nucleic acids including DNA plasmids and of the nucleic acid molecules produced by such processes;

VGX

The mark consists of the word VGX having 5 3-circle arms surrounding it, and each arm extending radially outward, with the circles having smaller diameters as they are further away from the center.;Color is not claimed as a feature of the mark.;scientific testing and analysis of cGMP (current good manufacturing practice) processes in the field of nucleic acids including DNA plasmids and of the nucleic acid molecules produced by such processes;